Sign In
Buy LLY
$1,192.80
+22.94 (+1.96%)
At Close: Aug 06, 2026
The Big 3: LLY, BA, CVS
12:01pm, Friday, 22'nd Aug 2025
Dan Deming considers Friday's trading action after Jerome Powell's Jackson Hole speech "remarkable." On stocks he's watching ahead, he expects Eli Lilly (LLY) to rebound off a significant sell-off, Bo
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 22'nd Aug 2025
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?
09:50am, Friday, 22'nd Aug 2025
Lilly's obesity pill orforglipron disappointed with lower weight loss, but its broad late-stage pipeline keeps growth hopes alive.
Lilly to participate in Wells Fargo 20th Annual Healthcare Conference
09:00am, Friday, 22'nd Aug 2025
INDIANAPOLIS , Aug. 22, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Wells Fargo 20th Annual Healthcare Conference on Sept. 5, 2025. Patrik Jonsson, executive vice pre
Eli Lilly and Company Investors: Company Investigated by the Portnoy Law Firm
05:25pm, Thursday, 21'st Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
One of the Best Stocks to Buy Now?
09:30am, Wednesday, 20'th Aug 2025
Eli Lilly (LLY -1.36%) stock investors need to be aware of these details before making a decision to buy or sell the stock.
What's Going on With Eli Lilly Stock?
09:23am, Wednesday, 20'th Aug 2025
Eli Lilly (LLY -1.36%) is one of my best stocks to buy in 2025.
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
09:00am, Wednesday, 20'th Aug 2025
INDIANAPOLIS , Aug. 20, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Anne White, executive vice president and president, Lilly Neuroscience, will be retiring from Li
Pharmaceuticals Industry Analysis: Eli Lilly Tops My Tier Two
04:16am, Wednesday, 20'th Aug 2025
I invest for long-term total return, focusing on high-quality, dividend-paying industry leaders with strong financials and consistent performance. Despite current headwinds like tariffs and patent exp
2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist
11:24am, Monday, 18'th Aug 2025
Key Points in This Article: Dividend growth investing offers stable income and capital appreciation through compounding returns.
Lilly Stock Down 5% This Month: Should You Buy the Dip?
10:15am, Monday, 18'th Aug 2025
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill orforglipron disappointed.
Eli Lilly: A Textbook Insider Buying Play
07:43am, Monday, 18'th Aug 2025
I initiate my coverage on Eli Lilly with a 'Buy' after an eventful Q2 earnings season. The stock looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbou
This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors
07:15am, Sunday, 17'th Aug 2025
After crushing the market over the past few years, Eli Lilly (LLY 2.73%) is finally feeling the effects of gravity. The company has faced a pair of setbacks this year.
3 Fantastic Growth Stocks to Buy in August
06:42am, Sunday, 17'th Aug 2025
We're well into the home stretch of 2025. August is more than halfway over.
Eli Lilly: Don't Bet Against This Biotech Powerhouse
01:30am, Sunday, 17'th Aug 2025
Eli Lilly's recent 20% pullback is a buy-the-dip opportunity, as the market overreacted to mixed Orforglipron results. Blockbuster drugs Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 9
